February 9, 2015
New York City-based Force Therapeutics raised $1.7 million in a round that the company started September 2013, according to an SEC filing. This brings the company's total funding to date to $2.2 million.
Existing investors include former OpenTable CEO Thomas Layton; former CEO of Revolution Health and TicketMaster, John Pleasants; and FiveW Capital Managing Member Randall Winn. The company raised...